Abstract
Objective: To describe the characteristics of patients with catastrophic antiphospholipid syndrome (APS) included in the International Registry of patients with this condition (CAPS registry) and to analyse the value of the recently proposed preliminary criteria for the classification of catastrophic APS.
Methods: A review of the first 220 patients included in the website based CAPS registry was undertaken and the preliminary criteria for their classification were tested; 175 unselected patients with systemic lupus erythematosus or APS, or both, acted as controls.
Results: The mean age of the patients was 38 (14) years (range 7 to 74), with a female preponderance (F/M, 153/67). The main clinical manifestations included renal involvement in 154 (70%), pulmonary in 146 (66%), cerebral in 133 (60%), cardiac in 115 (52%), and cutaneous in 104 (47%); 114 patients (52%) recovered after the catastrophic APS event (mortality 48%). Patients who received the combination of anticoagulation plus steroids plus plasma exchange or intravenous immunoglobulins had the best survival rate (63%, p = 0.09). Sufficient data could be analysed for application of the classification criteria in 176 patients. According to the preliminary criteria, 89 patients (51%) could be classified as having "definite" and 70 (40%) as having "probable" catastrophic APS, thus given a sensitivity of 90.3% with a specificity of 99.4%. Positive and negative predictive values were 99.4% and 91.1%, respectively.
Conclusions: The preliminary criteria for the classification of catastrophic APS and the CAPS registry are useful tools for epidemiological studies.
Full Text
The Full Text of this article is available as a PDF (74.6 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Asherson R. A., Cervera R. Catastrophic antiphospholipid syndrome. Curr Opin Hematol. 2000 Sep;7(5):325–329. doi: 10.1097/00062752-200009000-00012. [DOI] [PubMed] [Google Scholar]
- Asherson R. A., Cervera R., Piette J. C., Font J., Lie J. T., Burcoglu A., Lim K., Muñoz-Rodríguez F. J., Levy R. A., Boué F. Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine (Baltimore) 1998 May;77(3):195–207. doi: 10.1097/00005792-199805000-00005. [DOI] [PubMed] [Google Scholar]
- Asherson R. A., Cervera R., Piette J. C., Shoenfeld Y., Espinosa G., Petri M. A., Lim E., Lau T. C., Gurjal A., Jedryka-Góral A. Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) 2001 Nov;80(6):355–377. doi: 10.1097/00005792-200111000-00002. [DOI] [PubMed] [Google Scholar]
- Asherson R. A., Cervera R., de Groot P. G., Erkan D., Boffa M. C., Piette J. C., Khamashta M. A., Shoenfeld Y., Catastrophic Antiphospholipid Syndrome Registry Project Group Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus. 2003;12(7):530–534. doi: 10.1191/0961203303lu394oa. [DOI] [PubMed] [Google Scholar]
- Asherson R. A. The catastrophic antiphospholipid syndrome. J Rheumatol. 1992 Apr;19(4):508–512. [PubMed] [Google Scholar]
- Cervera Ricard, Piette Jean-Charles, Font Josep, Khamashta Munther A., Shoenfeld Yehuda, Camps María Teresa, Jacobsen Soren, Lakos Gabriella, Tincani Angela, Kontopoulou-Griva Irene. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002 Apr;46(4):1019–1027. doi: 10.1002/art.10187. [DOI] [PubMed] [Google Scholar]
- Erkan D., Asherson R. A., Espinosa G., Cervera R., Font J., Piette J-C, Lockshin M. D., Catastrophic Antiphospholipid Syndrome Registry Project Group Long term outcome of catastrophic antiphospholipid syndrome survivors. Ann Rheum Dis. 2003 Jun;62(6):530–533. doi: 10.1136/ard.62.6.530. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271–1277. doi: 10.1002/art.1780251101. [DOI] [PubMed] [Google Scholar]
- Westney Gloria E., Harris E. Nigel. Catastrophic antiphospholipid syndrome in the intensive care unit. Crit Care Clin. 2002 Oct;18(4):805–817. doi: 10.1016/s0749-0704(02)00026-x. [DOI] [PubMed] [Google Scholar]
- Wilson W. A., Gharavi A. E., Koike T., Lockshin M. D., Branch D. W., Piette J. C., Brey R., Derksen R., Harris E. N., Hughes G. R. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum. 1999 Jul;42(7):1309–1311. doi: 10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F. [DOI] [PubMed] [Google Scholar]